PHARMACIST-MANAGED MEDICATION REVIEW IN A MANAGED CARE SYSTEM

被引:56
作者
BORGSDORF, LR
MIANO, JS
KNAPP, KK
机构
[1] UNIV PACIFIC,SCH PHARM,STOCKTON,CA 95211
[2] KAISER PERMANENTE,BAKERSFIELD,CA
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1994年 / 51卷 / 06期
关键词
COSTS; DEMOGRAPHICS; DRUG USE; ECONOMICS; HEALTH CARE; HOSPITALS; MANAGED CARE SYSTEMS; PATIENT INFORMATION; PHARMACEUTICAL SERVICES; PHARMACISTS; INSTITUTIONAL;
D O I
10.1093/ajhp/51.6.772
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A medication-review service at a managed care facility was studied. The service, developed in 1991, provides in-depth analysis of medication use and patient consultation by a pharmacist. Patients are seen by referral. During a visit, the pharmacist reviews each medication for patterns of use, clinical response, and adverse effects and if necessary teaches the patient how to use the drugs more appropriately. The pharmacist may change some aspect of the prescription and may schedule follow-up visits. The investigators reviewed data on (1) medication-related problems for all new patients seen by the pharmacist during the first 12 months of the service, (2) patient demographics for the first 23 months, (3) utilization of the service and pharmacist productivity for the first 23 months, (4) utilization of medications and health care services in a representative subset of patients 12 months before and after they used the service, and (5) costs. A total of 2720 medications were reviewed during months 1-12. On average, 64.9% of the drugs reviewed each month were problematic. A total of 836 patients were seen during the first 23 months; most of the referrals were from physicians. The patients averaged 2.6 diagnoses and 4.7 drugs each and were not dominated by any one age group, gender, diagnosis, or drug therapy. A representative subgroup showed reductions in the number of unscheduled physician visits; urgent care visits, emergency room visits, and hospital days; a savings of $644 per patient per year was calculated. Patients used fewer health services during the year after they began participating in a pharmacist-managed medication-review program.
引用
收藏
页码:772 / 777
页数:6
相关论文
共 13 条
[1]   SUSTAINED IMPROVEMENT IN DRUG DOCUMENTATION, COMPLIANCE, AND DISEASE-CONTROL - A 4-YEAR ANALYSIS OF AN AMBULATORY CARE MODEL [J].
BOND, CA ;
MONSON, R .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (06) :1159-1162
[2]   IMPACT OF EDUCATION BY CLINICAL PHARMACISTS ON PHYSICIAN AMBULATORY CARE PRESCRIBING OF GENERIC VERSUS BRAND-NAME DRUGS [J].
ERRAMOUSPE, J .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (10) :770-773
[3]   EFFECT OF A CLINICAL PHARMACIST PROGRAM ON THE COST OF HYPERTENSION TREATMENT IN AN HMO FAMILY-PRACTICE CLINIC [J].
FORSTROM, MJ ;
RIED, LD ;
STERGACHIS, AS ;
CORLISS, DA .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (03) :304-309
[4]   PHARMACY CLINIC - NEW APPROACH TO AMBULATORY CARE [J].
GARDNER, ME ;
TRINCA, CE .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (04) :429-431
[5]   OPPORTUNITIES AND RESPONSIBILITIES IN PHARMACEUTICAL CARE [J].
HEPLER, CD ;
STRAND, LM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (03) :533-543
[6]  
LOBECK F, 1989, HOSP COMMUNITY PSYCH, V40, P643
[7]   MEDICATION USE IN AN IMPERFECT WORLD - DRUG MISADVENTURING AS AN ISSUE OF PUBLIC-POLICY .1. [J].
MANASSE, HR .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (05) :929-944
[8]   USE OF HISTAMINE2-RECEPTOR BLOCKING-AGENTS AND SUCRALFATE IN A HEALTH MAINTENANCE ORGANIZATION FOLLOWING CONTINUED CLINICAL PHARMACIST INTERVENTION [J].
MEAD, RA ;
MCGHAN, WF .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (06) :466-469
[9]   ROLE OF THE CLINICAL PHARMACIST IN IMPROVING DRUG-THERAPY - CLINICAL PHARMACISTS IN OUTPATIENT THERAPY [J].
MONSON, R ;
BOND, CA ;
SCHUNA, A .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (11) :1441-1444
[10]   IMPACT OF A PHARMACIST ON MEDICATION DISCONTINUATION IN A HOSPITAL-BASED GERIATRIC CLINIC [J].
PHILLIPS, SL ;
CARRLOPEZ, SM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (05) :1075-1079